Microbial Bioactives
Microbial Bioactives | Online ISSN 2209-2161
  1. You are here:
  2. Home
  3. Journals
  4. Biological Sciences
Microbial Bioactives
Latest Issue

Volume 8 Number 1 2025

Article Contents

REVIEWS   (Open Access)
Contents Vol 8 (1)

Probiotics as Emerging Neurotherapeutics in Spinal Cord Injury: Modulating Inflammation, Infection, and Regeneration

Md Sakil Amin1*, Md Jabir Rashid1, Tufael2, Azizur Rahman3

+ Author Affiliations

Microbial Bioactives 8 (1) 1-11 https://doi.org/10.25163/microbbioacts.8110290

Submitted: 11 May 2025 Revised: 06 July 2025  Published: 08 July 2025 

Abstract

Spinal cord injury (SCI) is a life-altering condition that often leads to severe motor, sensory, and autonomic dysfunction. The pathophysiology of SCI involves primary mechanical damage followed by secondary injury, characterized by inflammation, oxidative stress, and neurodegeneration. Traditional treatment options focus primarily on symptomatic relief and rehabilitation, with limited success in neural regeneration. In recent years, probiotics have emerged as potential therapeutic agents due to their antibacterial, anti-inflammatory, and neurodegenerative properties. Probiotics influence the gut microbiota, which plays a crucial role in modulating systemic inflammation, immune responses, and neuroprotection. Research suggests that probiotics can enhance neurogenesis, modulate cytokine production, and reduce secondary injury cascades in SCI models. Furthermore, probiotic-derived metabolites, such as short-chain fatty acids and neurotransmitters, contribute to neuroprotection and functional recovery. This review explores the potential of probiotics in SCI management by examining their mechanisms of action, including antibacterial defense, inflammation reduction, and neuronal repair. It also highlights clinical and preclinical studies supporting probiotic interventions for SCI. Given the growing interest in gut-brain interactions, understanding the therapeutic role of probiotics in SCI could lead to novel adjunct treatments, improving the quality of life for affected individuals. However, further research is required to establish standardized probiotic strains, dosages, and treatment regimens.

Keywords: Spinal cord injury, probiotics, neurodegeneration, gut microbiota, inflammation, antibacterial.

References

Allison, D. J., & Ditor, D. S. (2014). Immune dysfunction and chronic inflammation following spinal cord injury. Spinal Cord, 53(1), 14–18. https://doi.org/10.1038/sc.2014.184

Blais, L. L., Montgomery, T. L., Amiel, E., Deming, P. B., & Krementsov, D. N. (2021). Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review. Gut Microbes, 13(1). https://doi.org/10.1080/19490976.2021.1943289

Cardile, D., Calderone, A., De Luca, R., Corallo, F., Quartarone, A., & Calabrò, R. S. (2024). The Quality of Life in Patients with Spinal Cord Injury: Assessment and Rehabilitation. Journal of Clinical Medicine, 13(6), 1820. https://doi.org/10.3390/jcm13061820

Crowley, T., Cryan, J. F., Downer, E. J., & O’Leary, O. F. (2016). Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuro-immune interactions. Brain Behavior and Immunity, 54, 260–277. https://doi.org/10.1016/j.bbi.2016.02.001

Darbandi, A., Asadi, A., Ari, M. M., Ohadi, E., Talebi, M., Zadeh, M. H., Emamie, A. D., Ghanavati, R., & Kakanj, M. (2021). Bacteriocins: Properties and potential use as antimicrobials. Journal of Clinical Laboratory Analysis, 36(1). https://doi.org/10.1002/jcla.24093

Daughton, C. G., & Ruhoy, I. S. (2012). Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment. The Science of the Total Environment, 443, 324–337. https://doi.org/10.1016/j.scitotenv.2012.10.092

Dopkins, N., Nagarkatti, P. S., & Nagarkatti, M. (2018). The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders. Immunology, 154(2), 178–185. https://doi.org/10.1111/imm.12903

Faden, A. I., Wu, J., Stoica, B. A., & Loane, D. J. (2015). Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury. British Journal of Pharmacology, 173(4), 681–691. https://doi.org/10.1111/bph.13179

Fava, G. A., Cosci, F., Guidi, J., & Tomba, E. (2017). Well-being therapy in depression: New insights into the role of psychological well-being in the clinical process. Depression and Anxiety, 34(9), 801–808. https://doi.org/10.1002/da.22629

Freyermuth-Trujillo, X., Segura-Uribe, J. J., Salgado-Ceballos, H., Orozco-Barrios, C. E., & Coyoy-Salgado, A. (2022). Inflammation: a target for treatment in spinal cord injury. Cells, 11(17), 2692. https://doi.org/10.3390/cells11172692

Garcia-Arguello, L. Y., O’Horo, J. C., Farrell, A., Blakney, R., Sohail, M. R., Evans, C. T., & Safdar, N. (2016). Infections in the spinal cord-injured population: a systematic review. Spinal Cord, 55(6), 526–534. https://doi.org/10.1038/sc.2016.173

Ghassab, F. T., Mahmoudi, F. S., Tinjani, R. T., Meibodi, A. E., Zali, M. R., & Yadegar, A. (2024). Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights. Life Sciences, 350, 122748. https://doi.org/10.1016/j.lfs.2024.122748

Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A., & Covasa, M. (2022). Role of Microbiota-Gut-Brain axis in regulating dopaminergic signaling. Biomedicines, 10(2), 436. https://doi.org/10.3390/biomedicines10020436

Jamali, F., Mousavi, S., Homayouni-Rad, A., Meshkini, A., Alikhah, H., Houshyar, J., Moghadam, S. K., Yaghoubi, S. M., Asghari, K. M., Ilkhchi, M. T., & Alavi, S. a. N. (2025). Exploring Innovative Approaches for Managing Spinal cord Injury: A comprehensive review of promising probiotics and postbiotics. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-025-10513-6

Khalesi, S., Bellissimo, N., Vandelanotte, C., Williams, S., Stanley, D., & Irwin, C. (2018). A review of probiotic supplementation in healthy adults: helpful or hype? European Journal of Clinical Nutrition, 73(1), 24–37. https://doi.org/10.1038/s41430-018-0135-9

Lescheid, D. W. (2014). Probiotics as regulators of inflammation: A review. Functional Foods in Health and Disease, 4(7), 299. https://doi.org/10.31989/ffhd.v4i7.2

Leta, V., Chaudhuri, K. R., Milner, O., Chung-Faye, G., Metta, V., Pariante, C. M., & Borsini, A. (2021). Neurogenic and anti-inflammatory effects of probiotics in Parkinson’s disease: A systematic review of preclinical and clinical evidence. Brain Behavior and Immunity, 98, 59–73. https://doi.org/10.1016/j.bbi.2021.07.026

Llewellyn, A., & Foey, A. (2017). Probiotic Modulation of Innate Cell Pathogen Sensing and Signaling Events. Nutrients, 9(10), 1156. https://doi.org/10.3390/nu9101156

Mekhail, M., Almazan, G., & Tabrizian, M. (2012). Oligodendrocyte-protection and remyelination post-spinal cord injuries: A review. Progress in Neurobiology, 96(3), 322–339. https://doi.org/10.1016/j.pneurobio.2012.01.008

Preethy, S., Ranganathan, N., Raghavan, K., Dedeepiya, V. D., Ikewaki, N., & Abraham, S. J. (2022). Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders. Journal of Alzheimer S Disease, 87(4), 1451–1460. https://doi.org/10.3233/jad-220313

Ramsay, A. J., Kent, S. J., Strugnell, R. A., Suhrbier, A., Thomson, S. A., Ramshaw, I. A., Raima, A. J., Kent, S. J., Strugnell, R. A., Suhrbicr, A., Thomson, S. A., & Ramshaw, I. A. (1999). Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. Immunological Reviews, 171(1), 27–44. https://doi.org/10.1111/j.1600-065x.1999.tb01341.x

Sarubbo, F., Cavallucci, V., & Pani, G. (2022). The influence of gut microbiota on neurogenesis: Evidence and hopes. Cells, 11(3), 382. https://doi.org/10.3390/cells11030382

Sedgwick, J. D., Schwender, S., Imrich, H., Dörries, R., Butcher, G. W., & Ter Meulen, V. (1991). Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proceedings of the National Academy of Sciences, 88(16), 7438–7442. https://doi.org/10.1073/pnas.88.16.7438

Shamsnia, H. S., Peyrovinasab, A., Amirlou, D., Sirouskabiri, S., Rostamian, F., Basiri, N., Shalmani, L. M., Hashemi, M., Hushmandi, K., & Abdolghaffari, A. H. (2024b). BDNF-TRKB signaling pathway in spinal cord injury: Insights and implications. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04381-4

Sichetti, M., De Marco, S., Pagiotti, R., Traina, G., & Pietrella, D. (2018). Anti-inflammatory effect of multistrain probiotic formulation ( L. rhamnosus, B. lactis, and B. longum ). Nutrition, 53, 95–102. https://doi.org/10.1016/j.nut.2018.02.005

Siddique, M. A. B., Debnath, A., Nath, N. D., Biswash, M. A. R., & Tufael. (2018, March 2). Advancing medical science through nanobiotechnology: Prospects, applications, and future directions. Journal of Primeasia, 1(1), 1–7. https://doi.org/10.25163/primeasia.1110163

Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019). The pros, cons, and many unknowns of probiotics. Nature Medicine, 25(5), 716–729. https://doi.org/10.1038/s41591-019-0439-x

Suganya, K., & Koo, B. (2020). Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. International Journal of Molecular Sciences, 21(20), 7551. https://doi.org/10.3390/ijms21207551

Sun, Y., Wang, C., Wang, H., Yuan, Y., Lu, J., & Zhong, L. (2022). Probiotic in the prevention of ventilator-associated pneumonia in critically ill patients: evidence from meta-analysis and trial sequential analysis of randomized clinical trials. BMC Pulmonary Medicine, 22(1). https://doi.org/10.1186/s12890-022-01965-5

Tufael, M.?S.?B., Rana, M.?S., Das, S.?S., & Hossian, M. (2023). Nutritional evaluation of cassava meal components. Journal of Primeasia, 4(1), 1–4. https://doi.org/10.25163/angiotherapy.839572\

Umbrello, G., & Esposito, S. (2016). Microbiota and neurologic diseases: potential effects of probiotics. Journal of Translational Medicine, 14(1). https://doi.org/10.1186/s12967-016-1058-7

Venkatesh, K., Ghosh, S. K., Mullick, M., Manivasagam, G., & Sen, D. (2019). Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications. Cell and Tissue Research, 377(2), 125–151. https://doi.org/10.1007/s00441-019-03039-1

Wei, L., Ji, L., Miao, Y., Han, X., Li, Y., Wang, Z., Fu, J., Guo, L., Su, Y., & Zhang, Y. (2023). Constipation in DM are associated with both poor glycemic control and diabetic complications: Current status and future directions. Biomedicine & Pharmacotherapy, 165, 115202. https://doi.org/10.1016/j.biopha.2023.115202

Yadav, H., Jaldhi, N., Bhardwaj, R., Anamika, N., Bakshi, A., Gupta, S., & Maurya, S. K. (2023). Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review. Life Sciences, 330, 122022. https://doi.org/10.1016/j.lfs.2023.122022

Zhao, J., Yu, L., Zhai, Q., Tian, F., Zhang, H., & Chen, W. (2020). Effects of probiotic administration on hepatic antioxidative parameters depending on oxidative stress models: A meta-analysis of animal experiments. Journal of Functional Foods, 71, 103936. https://doi.org/10.1016/j.jff.2020.103936

 

PDF
Abstract
Export Citation

View Dimensions


View Plumx


View Altmetric



0
Save
0
Citation
94
View
0
Share